Total Payments
$114,076
2024 Payments
$2,691
Companies
34
Transactions
424
Medicare Patients
23,920
Medicare Billing
$2.0M
Payment Breakdown by Category
Other$83,998 (73.6%)
Food & Beverage$13,114 (11.5%)
Travel$10,639 (9.3%)
Consulting$6,291 (5.5%)
Education$34.34 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $83,998 | 46 | 73.6% |
| Food and Beverage | $13,114 | 330 | 11.5% |
| Travel and Lodging | $10,639 | 41 | 9.3% |
| Consulting Fee | $6,291 | 4 | 5.5% |
| Education | $34.34 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $33,378 | 97 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $21,427 | 37 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $18,551 | 37 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14,004 | 26 | $0 (2022) |
| Amarin Pharma Inc. | $11,483 | 20 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $6,107 | 53 | $0 (2024) |
| Boston Scientific Corporation | $2,265 | 23 | $0 (2024) |
| BIOTRONIK INC. | $2,029 | 32 | $0 (2024) |
| Lilly USA, LLC | $1,500 | 3 | $0 (2020) |
| Abbott Laboratories | $738.63 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,691 | 38 | Boston Scientific Corporation ($1,051) |
| 2023 | $3,069 | 40 | Boston Scientific Corporation ($1,080) |
| 2022 | $3,598 | 19 | Amgen Inc. ($2,996) |
| 2021 | $1,533 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($750.00) |
| 2020 | $12,423 | 38 | Amarin Pharma Inc. ($6,944) |
| 2019 | $56,222 | 114 | Amgen Inc. ($26,778) |
| 2018 | $18,121 | 78 | SANOFI-AVENTIS U.S. LLC ($8,022) |
| 2017 | $16,419 | 79 | Regeneron Healthcare Solutions, Inc. ($8,762) |
All Payment Transactions
424 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Boston Scientific Corporation | INGEVITY+ (Device) | Travel and Lodging | In-kind items and services | $220.00 | General |
| Category: Ingevity+_CRM | ||||||
| 12/13/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $152.73 | General |
| Category: General - Brady_CRM | ||||||
| 12/13/2024 | Boston Scientific Corporation | INGEVITY+ (Device) | Food and Beverage | In-kind items and services | $70.00 | General |
| Category: Ingevity+_CRM | ||||||
| 12/13/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $41.02 | General |
| Category: General - Brady_CRM | ||||||
| 12/13/2024 | Boston Scientific Corporation | INGEVITY+ (Device) | Travel and Lodging | In-kind items and services | $25.70 | General |
| Category: Ingevity+_CRM | ||||||
| 12/12/2024 | Boston Scientific Corporation | INGEVITY+ (Device) | Travel and Lodging | In-kind items and services | $245.94 | General |
| Category: Ingevity+_CRM | ||||||
| 12/12/2024 | Boston Scientific Corporation | INGEVITY+ (Device) | Travel and Lodging | In-kind items and services | $245.81 | General |
| Category: Ingevity+_CRM | ||||||
| 12/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: General - Brady_CRM | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.40 | General |
| Category: Cardiovascular | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Obesity | ||||||
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | BIOTRONIK INC. | Selectra (Device) | Food and Beverage | In-kind items and services | $39.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.48 | General |
| Category: Cardiology | ||||||
| 08/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $137.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $149.29 | General |
| Category: Cardiology | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $112.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $84.12 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: General - Therapies_CRM | ||||||
| 07/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $98.13 | General |
| Category: Obesity | ||||||
| 07/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 5,122 | 8,454 | $1.9M | $400,690 |
| 2022 | 49 | 6,211 | 8,024 | $2.3M | $495,265 |
| 2021 | 51 | 6,934 | 8,977 | $2.6M | $613,307 |
| 2020 | 46 | 5,653 | 7,283 | $2.1M | $508,532 |
Total Patients
23,920
Total Services
32,738
Medicare Billing
$2.0M
Procedure Codes
200
All Medicare Procedures & Services
200 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 588 | 612 | $407,592 | $86,342 | 21.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 145 | 145 | $224,025 | $48,087 | 21.5% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 11 | 11 | $195,965 | $36,626 | 18.7% |
| 75571 | Ct scan of heart with evaluation of blood vessel calcium | Office | 2023 | 436 | 436 | $145,188 | $30,416 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 299 | $104,949 | $25,509 | 24.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 90 | 360 | $51,264 | $16,064 | 31.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 79 | 79 | $52,614 | $12,600 | 23.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,028 | 1,103 | $60,665 | $10,639 | 17.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $46,110 | $9,980 | 21.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 68 | 68 | $44,540 | $8,669 | 19.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 48 | 88 | $29,656 | $7,982 | 26.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 155 | 155 | $35,650 | $7,368 | 20.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 53 | $24,910 | $6,692 | 26.9% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Office | 2023 | 31 | 31 | $38,967 | $6,631 | 17.0% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 48 | 48 | $29,088 | $6,582 | 22.6% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 16 | 16 | $29,408 | $6,010 | 20.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 27 | 27 | $26,406 | $5,743 | 21.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 41 | 245 | $9,555 | $5,685 | 59.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 78 | 102 | $21,252 | $5,527 | 26.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 161 | 161 | $36,618 | $5,382 | 14.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 90 | 253 | $25,300 | $5,000 | 19.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 96 | 101 | $24,341 | $4,930 | 20.3% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 115 | 328 | $26,896 | $4,819 | 17.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 40 | 244 | $21,228 | $4,225 | 19.9% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 18 | 19 | $15,067 | $3,299 | 21.9% |
About Dr. Ian Riddock, M.D
Dr. Ian Riddock, M.D is a Cardiovascular Disease healthcare provider based in Bend, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669582870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ian Riddock, M.D has received a total of $114,076 in payments from pharmaceutical and medical device companies, with $2,691 received in 2024. These payments were reported across 424 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($83,998).
As a Medicare-enrolled provider, Riddock has provided services to 23,920 Medicare beneficiaries, totaling 32,738 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 200 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Bend, OR
- Active Since 08/30/2006
- Last Updated 04/05/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1669582870
Products in Payments
- Repatha (Biological) $32,906
- PRALUENT (Drug) $15,776
- JARDIANCE (Drug) $15,334
- PRALUENT ALIROCUMAB INJECTION (Biological) $11,791
- Vascepa (Drug) $11,483
- PRALUENT (Biological) $10,085
- ENTRESTO (Drug) $5,181
- DISEASE STATE (Drug) $2,650
- LEQVIO (Drug) $914.27
- INGEVITY+ (Device) $807.45
- S-ICD System Magnet (Device) $715.97
- Confirm Rx (Device) $268.72
- Wegovy (Drug) $252.75
- Corlanor (Drug) $220.62
- XARELTO (Drug) $160.83
- NEXLETOL (Drug) $147.87
- EMBLEM MRI S-ICD (Device) $139.65
- Impella (Device) $137.45
- PRADAXA (Drug) $136.29
- NO PRODUCT DISCUSSED (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bend
Dr. Saurabh Gupta, Md, MD
Cardiovascular Disease — Payments: $944,834
Cardiovascular Disease $944,834
Jonathan Lowy, M.d, M.D
Cardiovascular Disease — Payments: $117,482
Cardiovascular Disease $117,482
Brian Mott, Md, MD
Cardiovascular Disease — Payments: $16,750
Cardiovascular Disease $16,750
Allen Rafael, Md, MD
Cardiovascular Disease — Payments: $2,826
Cardiovascular Disease $2,826
Dr. Kirk Walker, M.d, M.D
Cardiovascular Disease — Payments: $2,673
Cardiovascular Disease $2,673
Elizabeth Chandy, Md, MD
Cardiovascular Disease — Payments: $1,698
Cardiovascular Disease $1,698